Abstract Body

Background: Although prior research has found an association between erectile dysfunction medication (EDM) and increased sexual risk behavior, little is known about how frequently EDM is prescribed to HIV-infeced men who have sex with men (MSM) or about its association with increased sexual risk behavior nationally. Methodology: Using 2009 data from the Medical Monitoring Project, a nationally representative sample of HIV-infected adults receiving medical care in the United States, we assessed the characteristics of sexually active MSM, including men who have sex with men only and men who have sex with men and women, who were prescribed EDM and the independent association between EDM prescription and unprotected intercourse (UI) using multivariate logistic regression. EDM prescription was defined as documentation of sildenafil, vardenafil, or tadalafil in the medical record in the 12 months prior to interview. UI was defined as at least one episode of anal or vaginal sex without a condom during the 12 months prior to interview. All analyses accounted for clustering, unequal selection probabilities and non-response. Results: Among an estimated 136,320 sexually active HIV-infected MSM in care in the United States, 13% (95% Confidence Interval (CI) 10%-15%) received an EDM prescription and 56% (95% CI 50%-61%) had unprotected intercourse. MSM prescribed EDM were more likely to be aged 40 years or older, white or Hispanic, with college or higher education, above poverty level, insured, diagnosed with HIV for at least 5 years, having more than 5 sex partners, and those who used illicit drugs before or during sex. MSM prescribed EDM were significantly more likely (Prevalence Ratio 1.2; 95% CI 1.1-1.4) to have unprotected intercourse, while controlling for identified risk factors including race and ethnicity, total number of partners, depression, and illicit drug use before or during sex. Only 40% of MSM prescribed EDM had received counseling from their healthcare provider in the past 12 months on ways to protect themselves or partners from HIV or other STDs. Conclusions: HIV-infected sexually active MSM prescribed EDM were significantly more likely to have unprotected intercourse after adjusting for other independent predictors. Despite having been prescribed EDM by their HIV provider, only 40% of MSM received risk reduction counseling. HIV providers should be aware of the potential for increased HIV transmission risk associated with prescribed EDM use.